FDA Approves Genzyme’s AUBAGIO® (teriflunomide), a Once-Daily, Oral Treatment for Relapsing Multiple Sclerosis

View Full Size 

Download

• Full Size JPEG, 2200x1700, 332.4 KB
• Small JPEG, 480x371, 40.0 KB
• Preview JPEG, 144x111, 6.5 KB
• Thumbnail JPEG, 72x56, 2.3 KB